Literature DB >> 16092074

How to diagnose multiple system atrophy.

Niall P Quinn1.   

Abstract

The diagnosis of multiple system atrophy (MSA) in life remains entirely clinical. Consensus diagnostic criteria have been developed, but their use does not particularly render a diagnosis of MSA more accurate than are clinicians' diagnoses. Some patients may not fulfill the stipulated core diagnostic criteria, yet display many so-called red flags pointing toward MSA. The additional usefulness of these red flags and of a variety of investigations currently is being investigated, with a view to some of them being incorporated in future sets of diagnostic criteria. Copyright 2005 Movement Disorder Society.

Entities:  

Mesh:

Year:  2005        PMID: 16092074     DOI: 10.1002/mds.20534

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy.

Authors:  Jee-Young Lee; Ji Young Yun; Chae-Won Shin; Han-Joon Kim; Beom S Jeon
Journal:  J Neurol       Date:  2010-07-22       Impact factor: 4.849

Review 2.  [Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

Authors:  I Liepelt; W Maetzler; H-P Blaicher; T Gasser; D Berg
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

3.  Current and future treatments in multiple system atrophy.

Authors:  Christine D Esper; Stewart A Factor
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

4.  A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA).

Authors:  Claire S Barnes; Jiong Yan; George R Wilmot
Journal:  Doc Ophthalmol       Date:  2008-11-21       Impact factor: 2.379

5.  Eye of the tiger-like MRI in parkinsonian variant of multiple system atrophy.

Authors:  Ming-Hong Chang; Wan-Ling Hung; Yi-Chu Liao; Yi-Chung Lee; Peiyuan F Hsieh
Journal:  J Neural Transm (Vienna)       Date:  2009-05-07       Impact factor: 3.575

6.  Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Authors:  B Mollenhauer; M Bibl; H Esselmann; P Steinacker; C Trenkwalder; J Wiltfang; M Otto
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

7.  Improvement of Advanced Parkinson's Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience.

Authors:  Ahmed Rabie; Leo Verhagen Metman; Mazen Fakhry; Ayman Youssef Ezeldin Eassa; Wael Fouad; Ahmed Shakal; Konstantin V Slavin
Journal:  Brain Sci       Date:  2016-12-13

8.  Genome-wide estimate of the heritability of Multiple System Atrophy.

Authors:  M Federoff; T R Price; A Sailer; S Scholz; D Hernandez; A Nicolas; A B Singleton; M Nalls; H Houlden
Journal:  Parkinsonism Relat Disord       Date:  2015-11-05       Impact factor: 4.891

9.  An update on the cerebellar subtype of multiple system atrophy.

Authors:  Ludovico Ciolli; Florian Krismer; Ferdinando Nicoletti; Gregor K Wenning
Journal:  Cerebellum Ataxias       Date:  2014-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.